Peptides are intermediate products of protein hydrolysis and are compounds formed by connecting α-amino acids with peptide bonds. Their unique properties such as high selectivity, affinity and specificity for target molecules make them a versatile tool for drug development, diagnostics and bioanalytical research. Peptide technology involves the design, synthesis, and study of peptides. In the pharmaceutical industry, peptide technology is used to develop novel therapeutic agents that target specific disease pathways with high precision and efficacy.
Our company has a specialized peptide technology platform that provides one-stop services from customized peptides to registration and application, as well as the production of peptide drugs under regulatory conditions. Our platform has strong peptide synthesis capabilities, enabling the design and development of peptides for a wide range of applications, and can also solve the problems you encounter in long peptide synthesis, difficult peptide sequence synthesis, directed cyclization, directed modification, etc., ensuring the delivery of finished products on schedule with high quality and quantity.
Our Peptide Technology Platform
Our peptide technology platform offers a wide range of services in the field of biopharmaceuticals, including:
- Peptide design and synthesis. We are able to design and synthesize a wide range of peptides for specific needs, including therapeutic peptides, peptide vaccines and peptide libraries.
- Peptide modification and optimization. We can modify and optimize existing peptides to enhance their stability, bioavailability, and efficacy, using techniques such as cyclization, pegylation, and lipidation.
- Peptide screening and characterization. Our platform enables high-throughput screening of peptides for various applications, as well as comprehensive characterization of their physicochemical properties and biological activities.
- Peptide conjugation. We offer services for conjugating peptides to various molecules, such as proteins, antibodies, or nanoparticles, to create novel peptide-drug conjugates or targeted delivery systems.
- Peptide bioanalytical services. We provide bioanalytical services for peptides, including quantification, stability testing, and pharmacokinetic studies, to support preclinical and clinical development.
- Regulatory support. We can help navigate the regulatory requirements for peptides, including preparing regulatory submissions and addressing any questions or concerns from regulatory authorities.
Our Technologies
Our peptide technology platform features a number of advanced technologies to meet any of your needs, including:
- Solid phase synthesis technology
- Liquid phase synthesis technology
- Solid-liquid phase synthesis technology
- Non-classical solid phase synthesis technology
- Peptide modification technology
- Unnatural amino acid synthesis technology
- High performance liquid phase preparation technology
Key Features Of Our Peptide Technology Platform
- Rational design. We leverage advanced modeling software to design peptides with specific structures and functions, enabling precise targeting and interaction with biological targets.
- High-throughput synthesis. We utilize state-of-the-art technology for rapid and efficient synthesis of peptides in large quantities. This allows us to quickly produce large libraries of peptides for screening and testing purposes, enabling accelerated peptide drugs discovery and development time.
- Comprehensive characterization. We employ a range of analytical techniques, such as mass spectrometry, circular dichroism, and nuclear magnetic resonance spectroscopy, to thoroughly characterize the physicochemical properties and biological activity of our peptides.
- Customization and scalability. Our peptide technology platform is highly versatile and adaptable, allowing us to tailor peptide sequence, length, amino acid composition and properties. Additionally, our processes are scalable to support large-scale production and commercialization.
Related Services
It should be noted that our service is only used for research, not for clinical use.
